1,169 code entries across 838 active EviCore by Evernorth policies that Backwork has recorded as requiring prior authorization. Each policy links to its page and to the payer’s source.
Summary of the payer’s published policy. Not a coverage determination — confirm with EviCore by Evernorth before submitting.
1–50 of 838, by title
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Codes requiring prior authorization |
|---|---|---|
| Abatacept (Orencia) | Oct 1, 2021 |
|
| Abatacept (Orencia) | Sep 1, 2022 |
|
| Abatacept (Orencia) | Dec 1, 2019 |
|
|---|
| Abatacept (Orencia) | Nov 1, 2020 |
|
|---|
| Abatacept (Orencia) | Nov 2, 2018 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Oct 1, 2020 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Jun 1, 2017 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Mar 1, 2019 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Sep 1, 2019 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Aug 1, 2022 |
|
|---|
| AbobotulinumtoxinA (Dysport) | Sep 1, 2021 |
|
|---|
| Actemra (tocilizumab) | Oct 1, 2023 |
|
|---|
| Acthar Gel (repository corticotropin injection) | Feb 1, 2024 |
|
|---|
| Acthar Gel (repository corticotropin injection) | Feb 1, 2025 |
|
|---|
| Acthar Gel (repository corticotropin injection) | Jan 1, 2026 |
|
|---|
| Adakveo (crizanlizumab-tmca) | Jan 1, 2025 |
|
|---|
| Adakveo (crizanlizumab-tmca) | Feb 1, 2024 |
|
|---|
| Adakveo (crizanlizumab-tmca) | Jan 1, 2026 |
|
|---|
| Advate, Adynovate, Afstyla, Altuviiio, Eloctate, Esperoct, Jivi, Kogenate FS, Kovaltry, Obizur, Novoeight, Nuwiq, Recombinate, Xyntha (antihemophilic factor [recombinant]) Hemofil M, Koate-DVI (antihemophilic factor [plasma de | Aug 1, 2024 |
|
|---|
| Adzynma (ADAMTS13 recombinant-krhn) | Not recorded |
|
|---|
| Adzynma (ADAMTS13 recombinant-krhn) | Apr 1, 2024 |
|
|---|
| Adzynma (ADAMTS13 recombinant-krhn) | Apr 1, 2025 |
|
|---|
| Aflibercept (Eylea, Eylea HD, Pavblu) Injection | Not recorded |
|---|
| Aflibercept (Eylea, Eylea HD, Pavblu) Injection | May 1, 2025 |
|---|
| Aflibercept (Eylea, Eylea HD, Pavblu) Injection | Not recorded |
|---|
| Agalsidase Beta (Fabrazyme) | Sep 1, 2020 |
|
|---|
| Agalsidase Beta (Fabrazyme) | Aug 1, 2021 |
|
|---|
| Agalsidase Beta (Fabrazyme) | Oct 1, 2019 |
|
|---|
| Agalsidase Beta (Fabrazyme) | Jul 1, 2023 |
|
|---|
| Agalsidase Beta (Fabrazyme) | Jul 1, 2022 |
|
|---|
| Agalsidase Beta (Fabrazyme) | Jan 1, 2019 |
|
|---|
| Aldurazyme (laronidase) | Not recorded |
|
|---|
| Aldurazyme (laronidase) | Jun 1, 2025 |
|
|---|
| Aldurazyme (laronidase) | Jun 1, 2024 |
|
|---|
| Alemtuzumab (Lemtrada) | May 1, 2020 |
|
|---|
| Alemtuzumab (Lemtrada) | Apr 1, 2021 |
|
|---|
| Alemtuzumab (Lemtrada) | Feb 1, 2023 |
|
|---|
| Alemtuzumab (Lemtrada) | Mar 1, 2022 |
|
|---|
| Alemtuzumab (Lemtrada) | Jun 1, 2019 |
|
|---|
| Alemtuzumab (Lemtrada) | Jun 1, 2023 |
|
|---|
| Alemtuzumab (Lemtrada) | Jan 1, 2019 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Sep 1, 2020 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Jul 1, 2023 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Jul 1, 2022 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Jan 1, 2019 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Oct 1, 2019 |
|
|---|
| Alglucosidase Alfa (Lumizyme) | Aug 1, 2021 |
|
|---|
| Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | May 1, 2020 |
|---|
| Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Apr 1, 2023 |
|---|
| Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Apr 1, 2022 |
|---|